HEALTH SCIENCES AND THE DEVELOPMENT OF TRANSFUSION MEDICINE – THE IMPACT OF FOREIGN AID CUTS
Main Article Content
Abstract
The global blood supply is skewed to developed countries, where around 16% of the global population lives. Over 40% of all blood collections occur in Very High or High Human Development Index (VH/H-HDI) countries. The Low- and Medium-HDI (L/M-HDI) countries house around 84% of the global population. Blood donation rates in many Low- and Medium- Human Development Index (L/M-HDI) countries represents <1% of the national population. Yet, demand for blood in L/M-HDI countries is relatively high mainly due to maternal hemorrhage; other causes of anemia, e.g., malaria in under 5-years old children; HIV/AIDS; trauma and traffic accidents, armed conflicts, civil wars and insurgence.
Guided through WHO, many projects from developed countries have been launched or are still being implemented. Due to the recent financial fund humanitarian foreign aid cuts these have slowed down or stopped with their implementation which leads to a change in priorities and creates prolongation of existing challenges particularly in the health care and availability of safe blood. The gap between the developed (around 16% of the global population) and the developing countries (over 80% of the global population) will therefor rapidly increase.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
http://hdr.undp.org/en/content/human-development-index-hdi
2. WHO Blood Safety and Availability. Key Facts June 2020. Accessible at
https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability
3. Abdella, YE, Hajjeh, R, Smit Sibinga, CTh. Review – Availability and safety of blood transfusion during humanitarian emergencies. EMHJ 2018;24:778-88
4. WHO Global Status Report on Blood Safety and Availability 2016. Geneva 2017. Licence: CC BY-NC-SA 3.0 IGO
5. WHO Action framework to advance universal access to safe, effective and quality-assured blood products. 2020-2023. Geneva, 2020. Licence: CC BY-NC-SA 3.0 IGO
6. Guidance to identify barriers in blood services using the blood system self-assessment (BSS) tool. Geneva, World Health Organization 2023. Licence: CC BY-NC-SA 32.0 IGO
7. Web annex in Guidance to identify barriers in blood services using the blood system self-assessment (BSS) tool. Geneva, World Health Organization 2023. Licence: CC BY-NC-SA 32.0 IGO
8. Smit Sibinga, CTh, Oladejo, MA. Management and Operations of Transfusion Medicine: Impact of Policy, Planning, and Leadership on Bridging the Knowledge Gap. In: Maki Habib ed. Handbook of Research on the Evolution of IT and the Rise of the E-Society. Chapter 20. IGI Global, Hershey, PA, USA 2018:438-54
9. UN Millennium Development Goals 2000-2015. Accessible at New country classifications by income level: 2019-2020. Accessible at
http://blogs.worldbank.org/opendata/new-country-classifications-income-level-2019-2020
10. United Nations. Sustainable Development Goals. New York: United Nations; 2015. Accessible at
https://sustainabledevelopment.un.org/?menu=1300 .]
11. WHO Universal Health Coverage. Accessible at
http://www.who.int/universal_health_coverage/en/
12. WHO Model List of Essential Medicines, 21st edition Geneva, CH. 2019. Accessible at
http://www.who.int/medicines/publications/essentialmedicines/21st_EML.pdf
13. WHO Model List of Essential in-vitro Diagnostics, 1st edition, Geneva, CH. 2018. Accessible at
http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf
14. WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices. Geneva, CH. Licence: BY-NC-SA 3.0 IGO
15. WHO EMRO Strategic framework for blood safety and availability 2016-2025. Cairo, Egypt. Licence: CC BY-NC-SA 3.0 IGO
16. WHO Global Patient Safety Action Plan 2021-2030 ‘Towards Eliminating Patient Harm in Health Care’. Third Draft January 2021. Accessible at
https://www.who.int/docs/default-source/patient-safety/global-patient-safety-action-plan-2021-2030_third-draft_january-2021_web.pdf?sfvrsn=948f15d5_17
17. Pitman JP. The Influence and Impact of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) on Blood Transfusion Services in Africa. Case Studies from Namibia. Grafimedia Facilitair Bedrijf RuG, NL. 2015
18. WHO Aide Mémoires. Accessible as pdf at
https://www.who.int/bloodsafety
19. Abdella YE, Maryuningsih Soedarmono YS, Smit Sibinga CTh. Historical Background and Current Global Efforts. In: Eichbaum QG et al. Eds. Global Perspectives and Practices in Transfusion Medicine, Section 1 – History, Resolutions, Frameworks. AABB Press, Bethesda MD. 2023:1-26
20. Perspectives and Practices in Transfusion Medicine. Eichbaum QG et al. Eds. AABB Press, Bethesda, MD. 2023
21. United Nations Universal Declaration of Human Rights. 1948. Accessible at
www.un.org/en/documents/udhr/nde.shtml